Market Cap 73.04M
Revenue (ttm) 32.55M
Net Income (ttm) -6.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.99%
Debt to Equity Ratio 0.00
Volume 403,500
Avg Vol 672,568
Day's Range N/A - N/A
Shares Out 35.98M
Stochastic %K 3%
Beta 1.39
Analysts Strong Sell
Price Target $8.70

Company Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interfac...

Industry: Medical Devices
Sector: Healthcare
Phone: 617 996 9058
Website: myomo.com
Address:
45 Blue Sky Dr., Suite 101, Burlington, United States
StockOperator69
StockOperator69 Jul. 6 at 11:03 PM
$MYO insider buys just going to watch and see where the bottoms at someone definitely loaded up so could see a run in the future but not sure if we’ve hit the bottom
1 · Reply
xbizo
xbizo Jul. 5 at 3:22 PM
$MYO Let's give it a rest and focus on what is changing now. There are good thinkers on this board, and everyone comes with biases. Plus circumstance and viewpoint change over time. The one thing that has changed since investor day is the price. Is $2 a good entry price?
0 · Reply
DeanJ7575
DeanJ7575 Jul. 4 at 11:52 AM
$MYO Official Launch of MyoPro at Artalive Malaysia Artalive Malaysia is proud to announce the official launch of MyoPro®️, a powerful orthotic specially designed to help individuals who suffer from paralysis or weakness in the arms and hands due to neurological conditions. Developed in the United States and clinically proven, MyoPro is now offered exclusively by ArtaLive – making Malaysia the first country in Southeast Asia to introduce this technology to the public.
2 · Reply
alexpitti
alexpitti Jul. 4 at 12:15 AM
$MYO loved it at $5 hates it at $2.2 lmao
1 · Reply
alexpitti
alexpitti Jul. 3 at 10:11 PM
been a tough 6 weeks for $DCTH and $MYO still holding strong. others have been flattish. have a happy 4th of july $STXS $VFC $ABEO
1 · Reply
Big_Baggies
Big_Baggies Jul. 3 at 7:30 PM
$MYO Management's 2024 press release about them becoming in-network with BCBS/Massachusetts was disingenuous/misleading. They are covering L8701 L8702 only for missing limbs...in other words, they arent covering the myopro. Being in-network is irrelevant. They got me there with that PR.
2 · Reply
xbizo
xbizo Jul. 3 at 6:37 PM
$MYO Started building a new position today at $2.05. Had exited after the $100MM 2028 investor day. May not be the best idea I've ever had - that is to buy a falling knife before the bottom is clearly in....
1 · Reply
kurtb1969
kurtb1969 Jul. 3 at 4:48 PM
$MYO is trading at 2.1x sales, $EKSO is trading at 0.29x sales and $LFWD 0.33x sales after recent dilution. These stocks have traded at 10-100x sales in the past.
0 · Reply
DeanJ7575
DeanJ7575 Jul. 3 at 4:45 PM
$MYO bottom line is we need new management - if I’m wrong, please post
2 · Reply
kurtb1969
kurtb1969 Jul. 3 at 4:43 PM
$MYO is 1 year ahead of $LFWD and 2 years ahead of $EKSO. Ekso has had to build a business from scratch selling to individuals. As myo can attest that takes a while. The best time to buy tiny companies is when there is maximum pessimism. myo can easily go up 5x and ekso, lfwd 10-20x within 5 years.
0 · Reply
Latest News on MYO
Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript

May 7, 2025, 9:00 PM EDT - 2 months ago

Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript


Myomo to Host Investor & Analyst Day Event on June 18, 2025

May 1, 2025, 8:30 AM EDT - 2 months ago

Myomo to Host Investor & Analyst Day Event on June 18, 2025


Myomo to Report First Quarter 2025 Financial Results on May 7

Apr 30, 2025, 4:05 PM EDT - 2 months ago

Myomo to Report First Quarter 2025 Financial Results on May 7


Myomo Launches the MyoPro® 2x

Apr 30, 2025, 8:05 AM EDT - 2 months ago

Myomo Launches the MyoPro® 2x


Myomo Announces Upcoming Changes to its Board of Directors

Apr 10, 2025, 8:30 AM EDT - 3 months ago

Myomo Announces Upcoming Changes to its Board of Directors


Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript

Mar 10, 2025, 6:13 PM EDT - 4 months ago

Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript


Myomo, Inc. Announces Proposed Public Offering of Common Stock

Dec 4, 2024, 4:05 PM EST - 7 months ago

Myomo, Inc. Announces Proposed Public Offering of Common Stock


Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:11 PM EST - 8 months ago

Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript


CMS Decision And O&P Network Build Out Make Myomo A Buy

Nov 5, 2024, 3:30 PM EST - 8 months ago

CMS Decision And O&P Network Build Out Make Myomo A Buy


Myomo to Participate in Two Investor Conferences in September

Sep 5, 2024, 4:15 PM EDT - 10 months ago

Myomo to Participate in Two Investor Conferences in September


Myomo, Inc. (MYO) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 11:03 AM EDT - 11 months ago

Myomo, Inc. (MYO) Q2 2024 Earnings Call Transcript


Myomo Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 11 months ago

Myomo Reports Second Quarter 2024 Financial Results


Myomo, Inc. (MYO) Q1 2024 Earnings Call Transcript

May 8, 2024, 10:03 PM EDT - 1 year ago

Myomo, Inc. (MYO) Q1 2024 Earnings Call Transcript


Myomo Reports First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 1 year ago

Myomo Reports First Quarter 2024 Financial Results


Myomo Appoints Heather Getz to its Board of Directors

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Myomo Appoints Heather Getz to its Board of Directors


Myomo, Inc.: In Motion To Accelerating Revenue Growth

Mar 10, 2024, 3:00 AM EDT - 1 year ago

Myomo, Inc.: In Motion To Accelerating Revenue Growth


Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 8:10 PM EST - 1 year ago

Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript


Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Jan 17, 2024, 8:00 AM EST - 1 year ago

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog


Myomo: Market Severely Undervaluing Opportunity

Dec 1, 2023, 1:32 PM EST - 1 year ago

Myomo: Market Severely Undervaluing Opportunity


Myomo, Inc. (MYO) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 6:28 PM EST - 1 year ago

Myomo, Inc. (MYO) Q3 2023 Earnings Call Transcript


Myomo Announces Closing of $4.4 Million Public Offering

Aug 29, 2023, 4:05 PM EDT - 2 years ago

Myomo Announces Closing of $4.4 Million Public Offering


Myomo Announces Pricing of $4.4 Million Public Offering

Aug 25, 2023, 7:00 AM EDT - 2 years ago

Myomo Announces Pricing of $4.4 Million Public Offering


Myomo, Inc. Announces Proposed Public Offering

Aug 24, 2023, 4:15 PM EDT - 2 years ago

Myomo, Inc. Announces Proposed Public Offering


StockOperator69
StockOperator69 Jul. 6 at 11:03 PM
$MYO insider buys just going to watch and see where the bottoms at someone definitely loaded up so could see a run in the future but not sure if we’ve hit the bottom
1 · Reply
xbizo
xbizo Jul. 5 at 3:22 PM
$MYO Let's give it a rest and focus on what is changing now. There are good thinkers on this board, and everyone comes with biases. Plus circumstance and viewpoint change over time. The one thing that has changed since investor day is the price. Is $2 a good entry price?
0 · Reply
DeanJ7575
DeanJ7575 Jul. 4 at 11:52 AM
$MYO Official Launch of MyoPro at Artalive Malaysia Artalive Malaysia is proud to announce the official launch of MyoPro®️, a powerful orthotic specially designed to help individuals who suffer from paralysis or weakness in the arms and hands due to neurological conditions. Developed in the United States and clinically proven, MyoPro is now offered exclusively by ArtaLive – making Malaysia the first country in Southeast Asia to introduce this technology to the public.
2 · Reply
alexpitti
alexpitti Jul. 4 at 12:15 AM
$MYO loved it at $5 hates it at $2.2 lmao
1 · Reply
alexpitti
alexpitti Jul. 3 at 10:11 PM
been a tough 6 weeks for $DCTH and $MYO still holding strong. others have been flattish. have a happy 4th of july $STXS $VFC $ABEO
1 · Reply
Big_Baggies
Big_Baggies Jul. 3 at 7:30 PM
$MYO Management's 2024 press release about them becoming in-network with BCBS/Massachusetts was disingenuous/misleading. They are covering L8701 L8702 only for missing limbs...in other words, they arent covering the myopro. Being in-network is irrelevant. They got me there with that PR.
2 · Reply
xbizo
xbizo Jul. 3 at 6:37 PM
$MYO Started building a new position today at $2.05. Had exited after the $100MM 2028 investor day. May not be the best idea I've ever had - that is to buy a falling knife before the bottom is clearly in....
1 · Reply
kurtb1969
kurtb1969 Jul. 3 at 4:48 PM
$MYO is trading at 2.1x sales, $EKSO is trading at 0.29x sales and $LFWD 0.33x sales after recent dilution. These stocks have traded at 10-100x sales in the past.
0 · Reply
DeanJ7575
DeanJ7575 Jul. 3 at 4:45 PM
$MYO bottom line is we need new management - if I’m wrong, please post
2 · Reply
kurtb1969
kurtb1969 Jul. 3 at 4:43 PM
$MYO is 1 year ahead of $LFWD and 2 years ahead of $EKSO. Ekso has had to build a business from scratch selling to individuals. As myo can attest that takes a while. The best time to buy tiny companies is when there is maximum pessimism. myo can easily go up 5x and ekso, lfwd 10-20x within 5 years.
0 · Reply
kurtb1969
kurtb1969 Jul. 3 at 4:35 PM
$MYO big baggies hates me because I believe exo skeletons are the future and I believe $MYO, $EKSO and $LFWD are the exo trifecta and are connected. No one wanted to buy $MYO 2 and a half years ago and because of tax loss selling was down to 50 cents. They ended up diluting existing shareholders by selling 20 million shares for 33 cents a share on 1/7-10/23. I was livid because I had 220k and was down $60K and if they waited 2 months they would have gotten a better price. This year so far myo is down 67 percent, ekso down 60 percent and lfwd down 60 percent. I believe they are connected and now they are at the bottom.
1 · Reply
Astondb9
Astondb9 Jul. 3 at 2:26 PM
$MYO rejected 5dma (2.15) again. Lower bb 1.89. Expense > Revenue = an issue. Pushing out breakeven cf time frame means erosion of cash-->requiring further dilution. That's what the mkt is sniffing out.
1 · Reply
NickMitchell
NickMitchell Jul. 2 at 9:35 PM
$MYO i blame Obama
2 · Reply
Rroper
Rroper Jul. 2 at 9:27 PM
$MYO Loaded a few more today. Slow and steady. Next year play. Paytience.
1 · Reply
alexpitti
alexpitti Jul. 2 at 9:06 PM
weak sector starting in early june especially $DCTH and $MYO
0 · Reply
kurtb1969
kurtb1969 Jul. 2 at 6:39 PM
$MYO very excited unloaded all my shares over $5 and now I'm fully loaded again. I believe the bad 2nd is over the outlook should be good.Myo exceeds estimates every quarter and now I'm up to a lucky 66600 shares.
2 · Reply
Astondb9
Astondb9 Jul. 2 at 2:09 PM
$MYO another day, another 5dma rejection while lower daily bb dips lower and lower. Now at 1.96 🫣😬🤕🤮🥴🥺
0 · Reply
alexpitti
alexpitti Jul. 2 at 4:17 AM
$MYO is myomo really doing terrible or is Q2 one bad quarter? numbers don't lie
1 · Reply
alexpitti
alexpitti Jul. 2 at 4:14 AM
$MYO I actually do think the narrative among retail investors is important because this is a pretty tiny stock. and if that's the case, a lot of the negativity is rooted in anger more than actual math and facts. i don't think many actually watched the investor meeting nor have they done the math and completed a valuation model on 2028 numbers. sure anyone can argue that they want myomo to grow faster in the next few years. but that's simply and irrelevant point because the market isn't even pricing in them hitting the 2028 guidance in the first place. in fact, the market isn't pricing in any growth at all. that's why we have a below 2x sales multiple
1 · Reply
Big_Baggies
Big_Baggies Jul. 1 at 6:38 PM
$MYO 11 days in a row of lower highs? What a mess. Very much a turd.
2 · Reply
fitchbuck
fitchbuck Jul. 1 at 4:47 PM
$MYO Everyone - take off your rose-colored-glasses-of-ownership for a second, put the hopium pipe down, and take a serious stab at answering these: When do believe the stock price sees $5 again? What do you put the % chance that this never gets to $5 again? (Hint: it's not 0.)
5 · Reply
Astondb9
Astondb9 Jul. 1 at 3:40 PM
$MYO 2.23 is the 5dma. Bounced off lower daily bb. Will it reject and head back to lower bb? Still believe weekly bb is the target 1.7
1 · Reply